Literature DB >> 17331965

Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21.

E M Pierce1, K Carpenter, C Jakubzick, S L Kunkel, H Evanoff, K R Flaherty, F J Martinez, G B Toews, C M Hogaboam.   

Abstract

Idiopathic pulmonary fibrosis (IPF)/usual interstitial pneumonia (UIP) is the severest form of idiopathic interstitial pneumonia for which therapeutic targets are needed. Surgical lung biopsy specimens from IPF/UIP patients exhibit focal expression of CC chemokine receptor (CCR) 7, but the identity of these CCR7-positive cells is unknown. The purpose of the present study was to examine the functional and signalling significance of CCR7 expression of primary fibroblasts grown from IPF/UIP and normal surgical lung biopsy specimens. Primary fibroblasts were cultured from surgical lung biopsy specimens from IPF/UIP and normal patients. Fibroblasts treated with or without CC chemokine ligand (CCL) 21 were analysed for functional, transcriptional and proteomic differences using immunocytochemical analysis, gene arrays, Taqman real-time PCR, and migration, proliferation and Western blot assays. CCR7 was expressed by IPF/UIP fibroblasts, but not normal fibroblasts. IPF/UIP fibroblasts, but not normal fibroblasts, showed significant migratory and proliferative responses when exposed to CCL21, which were inhibited by pertussis toxin or neutralising antibodies to CCR7. Exposure of IPF/UIP fibroblasts to CCL21 altered the phosphorylation status of mitogen-activated protein kinase kinase 1/2, extracellular signal-regulated kinase 1/2 and ribosomal S6 kinase (90 kDa) in these cells; this was abrogated by pertussis toxin or CCR7-specific small interfering RNA. Together, these data demonstrate that CC chemokine ligand 21 modulates the functional properties of idiopathic pulmonary fibrosis/usual interstitial pneumonia fibroblasts, but not normal fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331965     DOI: 10.1183/09031936.00122806

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  26 in total

Review 1.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

Review 2.  Inflammation-associated lymphangiogenesis: a double-edged sword?

Authors:  Honsoul Kim; Raghu P Kataru; Gou Young Koh
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

3.  Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells.

Authors:  Selami Demirci; Ayşegül Doğan; Hüseyin Apdik; Emre Can Tuysuz; Sukru Gulluoglu; Omer Faruk Bayrak; Fikrettin Şahin
Journal:  Mol Cell Biochem       Date:  2017-06-15       Impact factor: 3.396

4.  Identification of periplakin as a major regulator of lung injury and repair in mice.

Authors:  Valérie Besnard; Rania Dagher; Tania Madjer; Audrey Joannes; Madeleine Jaillet; Martin Kolb; Philippe Bonniaud; Lynne A Murray; Matthew A Sleeman; Bruno Crestani
Journal:  JCI Insight       Date:  2018-03-08

Review 5.  Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease.

Authors:  Souheil El-Chemaly; Gustavo Pacheco-Rodriguez; Yoshihiko Ikeda; Daniela Malide; Joel Moss
Journal:  Lymphat Res Biol       Date:  2009-12       Impact factor: 2.589

6.  Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.

Authors:  Souheil El-Chemaly; Daniela Malide; Enrique Zudaire; Yoshihiko Ikeda; Benjamin A Weinberg; Gustavo Pacheco-Rodriguez; Ivan O Rosas; Marta Aparicio; Ping Ren; Sandra D MacDonald; Hai-Ping Wu; Steven D Nathan; Frank Cuttitta; J Philip McCoy; Bernadette R Gochuico; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

7.  Immunization with recombinant Pb27 protein reduces the levels of pulmonary fibrosis caused by the inflammatory response against Paracoccidioides brasiliensis.

Authors:  Elis Araujo Morais; Estefânia Mara do Nascimento Martins; Jankerle Neves Boelone; Dawidson Assis Gomes; Alfredo Miranda Goes
Journal:  Mycopathologia       Date:  2014-12-09       Impact factor: 2.574

8.  T regulatory cells and attenuated bleomycin-induced fibrosis in lungs of CCR7-/- mice.

Authors:  Glenda Trujillo; Adam J Hartigan; Cory M Hogaboam
Journal:  Fibrogenesis Tissue Repair       Date:  2010-09-03

9.  Integrated pharmacokinetic, pharmacodynamic and immunogenicity profiling of an anti-CCL21 monoclonal antibody in cynomolgus monkeys.

Authors:  S Dudal; K Subramanian; T Flandre; W S Law; P J Lowe; A Skerjanec; J-C Genin; M Duval; A Piequet; A Cordier; G Jarai; G Van Heeke; S Taplin; C Krantz; S Jones; A P Warren; F R Brennan; J Sims; P Lloyd
Journal:  MAbs       Date:  2015       Impact factor: 5.857

10.  Matrix-driven Myosin II Mediates the Pro-fibrotic Fibroblast Phenotype.

Authors:  Brian D Southern; Lisa M Grove; Shaik O Rahaman; Susamma Abraham; Rachel G Scheraga; Kathryn A Niese; Huanxing Sun; Erica L Herzog; Fei Liu; Daniel J Tschumperlin; Thomas T Egelhoff; Steven S Rosenfeld; Mitchell A Olman
Journal:  J Biol Chem       Date:  2016-01-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.